Anders Bue Klein (@bueklein) 's Twitter Profile
Anders Bue Klein

@bueklein

CEO, Ousia Pharma

ID: 1201362930111012865

calendar_today02-12-2019 04:51:20

8 Tweet

144 Followers

161 Following

Petrine Wellendorph (@pwellendorph1) 's Twitter Profile Photo

VERY EXCITED TO SHARE THIS bioRxiv where we reveal the identity of the long-sought GHB high-affinity binding site to be CaMKIIa. biorxiv.org/content/10.110… See thread 👇 for an amazing journey of excellent collaborative and scientific effort. 1/6

Christoffer Clemmensen (@clemmensenc) 's Twitter Profile Photo

(1/9) New paper out in Translational Psychiatry in which we do a deep dive pre-clinical evaluation of the psychedelic, psilocybin, for obesity treatment. Credit to PhD candidate Nicole Fadahunsi + several lab members for excellent execution. Open access: nature.com/articles/s4139…

Ana Miguel Cruz, PhD 🇪🇺🇵🇹 (@anamiguelcruz) 's Twitter Profile Photo

In session 2 we had incredible talks from Ousia Pharma CSO Anders Klein Anders Bue Klein, Bayer | Pharmaceuticals representative Peter Sandner and SPARK programme director Ditte Riber about their very rich careers and what steps we need to take to work with/in Industry and for commercialisation

Samuel Kohtala (@samuelkohtala) 's Twitter Profile Photo

Our latest study is now out, raising important questions about the nature of antidepressant and anesthetic induced TrkB signaling. We discovered that many drugs regulate TrkB phosphorylation via body temperature. pubs.acs.org/doi/10.1021/ac…